1281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C
Invited conference paper presented and published in conference proceedings
Full Text
Digital Object Identifier (DOI) DOI for CUHK Users View Full-text in Publisher Website |
Altmetrics Information
.
Other information
All Author(s) ListDziadziuszko R., Peters S., Gadgeel S.M., Mathisen M.S., Shagan S.M., Felip E., Morabito A., Cheema P., Dols M.Cobo, Andric Z., Barrios C.H., Yamaguchi M., Dansin E., Danchaivijitr P., Johnson M., Novello S., Gandara D.R., Schleifman E., Wang J., Mok T.S.K.
Name of ConferenceESMO Congress 2021
Start Date of Conference16/09/2021
End Date of Conference21/09/2021
Place of ConferenceParis
Country/Region of ConferenceFrance
Proceedings TitleAnnals of Oncology
Year2021
Month9
Volume Number32
Issue NumberSuppl 5
PagesS950 - S951
ISSN0923-7534
LanguagesEnglish-United States
